3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Phase 4
1
Status
Unknown
1
Completed
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Thoracic
2
Other solid neoplasm
1
Conditions
Lung Diseases
2
Respiratory Aspiration
1
Pulmonary Atelectasis
1
Pneumothorax
1
Pleural Neoplasms
1
Pleural Effusion, Malignant
1
Pleural Diseases
1
Pericardial Effusion
1
Mesothelioma, Malignant
1
Lung Neoplasms
1
Hemothorax
1
Empyema, Pleural
1
Interventions
Carboplatin
10
Paclitaxel
5
Nivolumab
4
Pemetrexed
3
Cisplatin
3
atezolizumab
2
apatinib
2
Surveys and Questionnaires
2
One-Lung Ventilation
2
Ipilimumab
2
Blood Specimen Collection
2
Bevacizumab
2
zimberelimab
1
toripalimab
1
spartalizumab
1
sitravatinib
1
sintilimab
1
sacituzumab govitecan
1
pembrolizumab
1
lorlatinib
1
cemiplimab
1
camrelizumab
1
Vital Signs
1
Vinorelbine
1
Tyrosine Kinase Inhibitors
1
Tomography, Emission-Computed, Single-Photon
1
Temozolomide
1
Telescopes
1
Talc
1
Saline Solution
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
OTHER
×
Lung Diseases
×
One-Lung Ventilation
×
Clear all
NCT00534690
2026-05-15
REVOLU
University Hospital, Bordeaux
Phase NA
Completed
88 enrolled
NCT05077111
2021-10-14
VATS
Ain Shams University
Phase 4
Unknown
40 enrolled